Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Bullboard Posts
Post by drjekylon Aug 22, 2017 3:07pm
192 Views
Post# 26609040

ok, here's my take

ok, here's my takekayaker, that sounded like a JD response. 
jd, what happened to your website?
digi, you're a putz. 
this is what I see;
1. dilution
b. delays 
3. excessive g&a
4. delays
e. consolidation 
f. disention
7. restructuring
h. redo
9. more delays

thats just my observation from where I'm sitting. 
maybe JD has a better take but then again, he's paid for his observation. 

these are my thoughts, not yours, I'm..........
drj!

Bullboard Posts